Oakbrook Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-22,700
Closed -$2.25M 648
2019
Q3
$2.25M Sell
22,700
-4,300
-16% -$409K 0.15% 95
2019
Q2
$2.5M Sell
27,000
-180
-0.7% -$17.1K 0.15% 95
2019
Q1
$2.56M Sell
27,180
-24,430
-47% -$2.14M 0.16% 105
2018
Q4
$3.31M Buy
51,610
+23,860
+86% +$1.76M 0.22% 72
2018
Q3
$2.48M Sell
27,750
-14,575
-34% -$1.29M 0.14% 124
2018
Q2
$3.36M Sell
42,325
-4,108
-9% -$341K 0.21% 79
2018
Q1
$4.14M Buy
46,433
+4,655
+11% +$447K 0.26% 63
2017
Q4
$4.36M Buy
41,778
+7,425
+22% +$838K 0.28% 63
2017
Q3
$5.01M Sell
34,353
-5,525
-14% -$753K 0.32% 56
2017
Q2
$5.18M Sell
39,878
-4,225
-10% -$518K 0.34% 59
2017
Q1
$5.49M Buy
44,103
+600
+1% +$71.8K 0.36% 61
2016
Q4
$5.04M Sell
43,503
-10,200
-19% -$1.14M 0.33% 63
2016
Q3
$5.61M Sell
53,703
-7,900
-13% -$855K 0.34% 61
2016
Q2
$6.08M Buy
61,603
+17,900
+41% +$1.85M 0.34% 67
2016
Q1
$4.37M Buy
43,703
+33,625
+334% +$3.46M 0.28% 77
2015
Q4
$1.21M Sell
10,078
-38,075
-79% -$4.41M 0.08% 214
2015
Q3
$5.21M Buy
48,153
+38,250
+386% +$4.75M 0.34% 65
2015
Q2
$1.15M Sell
9,903
-2,850
-22% -$326K 0.07% 247
2015
Q1
$1.47M Buy
12,753
+925
+8% +$111K 0.08% 233
2014
Q4
$1.32M Buy
11,828
+4,200
+55% +$443K 0.07% 248
2014
Q3
$723K Sell
7,628
-115,050
-94% -$10.4M 0.04% 307
2014
Q2
$10.5M Sell
122,678
-6,000
-5% -$456K 0.32% 83
2014
Q1
$8.98M Sell
128,678
-118,800
-48% -$9.41M 0.28% 81
2013
Q4
$20.9M Sell
247,478
-27,222
-10% -$2.15M 0.58% 44
2013
Q3
$21.2M Sell
274,700
-14,900
-5% -$1.04M 0.62% 44
2013
Q2
$16.9M Buy
+289,600
New +$17.4M 0.49% 49

Other funds holding CELG

Oakbrook Investments's CELG Position: Q4 2019 in Review

Oakbrook Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 22,700 shares — an estimated $2.25M sold.

Oakbrook Investments first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $21.2M in Q3 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Oakbrook Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Oakbrook Investments sold 22,700 Celgene Corp shares in Q4 2019, an estimated $2.25M.
  • Oakbrook Investments first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Oakbrook Investments's Celgene Corp position peaked at $21.2M in Q3 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Oakbrook Investments's 13F filing for Q4 2019, filed 6 Feb 2020.